Conduct Smarter Oncology R&D Faster with SpecimenSeq
Bridging a deep understanding of molecular profiles is critical to developing innovative precision medicine tools in oncology. SpecimenSeq makes this challenge easier for targeted oncology developers by delivering access to ethically collected biospecimens that are comprehensively annotated by genomic and pathological characteristics.
FFPE & Plasma
DTCs & Sets
AML BMMCsand PBMCs
Verification of the presence of biomarker targets in your populations of interest
Confirmation of driver mutations and other clinically relevant genomic variants across FFPE samples
Acceleration of timelines for identifying responders versus non-responders and efficacy evaluations for new cancer therapies
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!